Compare Amylx Pharmaceuticals Inc (AMLX) vs OneSpan Inc (OSPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs OneSpan Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 4.4× OneSpan Inc's market cap, and OneSpan Inc pays a 3.19% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | OSPN | |
|---|---|---|
Market Cap | $2.64B | $600.69M |
Sector | Health | Technology |
52-Week High | $24.19 | $16.78 |
52-Week Low | $7.82 | $10.15 |
Enterprise Value | $2.39B | $569.77M |
Dividend Yield | — | 3.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
